Plague - 2018 Pipeline Insight Report: Features Takeda Pharma, iBio, GlaxoSmithKline, Syntiron, AvidBiotics, and more - ResearchAndMarkets.com

The "Plague - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Scope

• The report provides a snapshot of the pipeline development for the Plague
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Plague
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Plague
• The report also covers the dormant and discontinued pipeline projects related to the Plague

Key Topics Covered

1. Report Introduction

2. Plague Overview

3. Pipeline Therapeutics

• An Overview of Pipeline Products for Plague

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

7. Therapeutic Assessment

• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name: Company Name

• Product Description
• Research and Development
• Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/ksqf36/plague_2018?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005370/en/